Medifast, Inc. (Medifast) is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and diet products. The Company operates through its subsidiaries, Jason Pharmaceuticals, Inc., Take Shape For Life, Inc., Jason Enterprises, Inc., Medifast Franchise Systems (MFSI), Inc., Jason Properties, LLC, Medifast Nutrition, Inc. and Seven Crondall, LLC. Its product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. It provides weight loss, weight management and healthy living products and programs through multiple channels of distribution: direct to consumer channel through its Website and in-house call centers; Take Shape For Life; Franchise Medifast Weight Control Centers, and a national network of physicians. It offers its products under the Medifast, Thrive by Medifast, Optimal Health by Take Shape For Life and Essential 1 brands.
Industry, Sector and Symbol:
- Sector: Consumer Staples
- Industry: Specialty Retail, Other
- Sub-Industry: Personal Products
- Exchange: NYSE
- Symbol: MED
- CUSIP: 58470H10
- Previous Close: $44.96
- 50 Day Moving Average: $42.56
- 200 Day Moving Average: $39.94
- 52-Week Range: $11,848,000.00 - $27.64
- Trailing P/E Ratio: 30.48
- Foreward P/E Ratio: 21.83
- P/E Growth: 1.41
- Market Cap: $532.69M
- Outstanding Shares: 11,848,000
- Beta: 0.54
- Net Margins: 6.43%
- Return on Equity: 24.64%
- Return on Assets: 18.79%
Companies Related to Medifast:
- Current Ratio: 3.97%
- Quick Ratio: 3.39%
What is Medifast's stock symbol?
Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."
How often does Medifast pay dividends? What is the dividend yield for Medifast?
Medifast announced a quarterly dividend on Friday, December 9th. Investors of record on Friday, December 23rd will be paid a dividend of $0.32 per share on Thursday, February 9th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 2.85%. The ex-dividend date of this dividend is Wednesday, December 21st. This is an increase from Medifast's previous quarterly dividend of $0.25.
Where is Medifast's stock going? Where will Medifast's stock price be in 2017?
1 brokerages have issued twelve-month target prices for Medifast's shares. Their forecasts range from $36.00 to $36.00. On average, they expect Medifast's share price to reach $36.00 in the next year.
When will Medifast announce their earnings?
Medifast is scheduled to release their next quarterly earnings announcement on Wednesday, March, 8th 2017.
Who owns Medifast stock?
Medifast's stock is owned by many different of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (8.03%), Engaged Capital Flagship Master Fund, LP (6.50%), Dimensional Fund Advisors LP (5.15%), Numeric Investors LLC (4.39%), State Street Corp (2.64%) and AQR Capital Management LLC (1.12%). Company insiders that own Medifast stock include Balanced Master Fund L Visium, Barry B Bondroff, Glenn W Welling, Jeffrey J Brown, John P Mcdaniel, Margaret Sheetz and Moduslink Global Solutions Inc.
Who sold Medifast stock? Who is selling Medifast stock?
Medifast's stock was sold by a variety of institutional investors in the last quarter, including Numeric Investors LLC, Oxford Asset Management, GSA Capital Partners LLP, Federated Investors Inc. PA, AQR Capital Management LLC, Cadence Capital Management LLC and Systematic Financial Management LP. Company insiders that have sold Medifast stock in the last year include Balanced Master Fund L Visium and Margaret Sheetz.
Who bought Medifast stock? Who is buying Medifast stock?
Medifast's stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Dimensional Fund Advisors LP, State Street Corp, Menta Capital LLC, O Shaughnessy Asset Management LLC, Renaissance Technologies LLC, Tudor Investment Corp Et Al and New York State Teachers Retirement System. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling and Jeffrey J Brown.
How do I buy Medifast stock?
Shares of Medifast can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Medifast stock cost?
One share of Medifast stock can currently be purchased for approximately $44.96.